Navigation Links
MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease

ence and severity of adverse events (AEs) were comparable for both treatment groups and were consistent with prior experience with Synagis. There were comparable rates of related AEs and drug discontinuations between treatment groups [related AEs: motavizumab (N=298, 9.0 percent) vs. Synagis (N=258, 7.8 percent) p=not significant (NS); discontinuations: motavizumab (N=13, 0.4 percent) vs. Synagis (N=10, 0.3 percent) p=NS]. AEs related to skin hypersensitivity reactions resulted in discontinuation of dosing in motavizumab-treated patients at low frequency (N=9, 0.3 percent). In Synagis-treated patients, there were no AEs consistent with skin hypersensitivity reactions that resulted in dosing discontinuation. The overall mortality rates were not statistically different between the two groups (N=8, 0.2 percent motavizumab and N=4, 0.1 percent Synagis); no death was considered to be related to the study drugs and there were no RSV-related deaths. Immunogenicity in the motavizumab arm was less than 1 percent and comparable to the historical Synagis rate.

The trial was a randomized, double-blind study involving 6,635 high-risk infants at 347 centers in 24 countries through three RSV seasons. Study participants comprised premature infants born at 35 weeks gestational age or less who were six months of age or younger at randomization, as well as children with CLD related to prematurity requiring medical management within the six months prior to study entry, who were 24 months of age or less at randomization.

About RSV

Each year, an estimated 125,000 infants in the U.S. are hospitalized with severe RSV infections, the leading cause of lower respiratory tract infections in infants in the United States. RSV is the most common respiratory infection in infancy or childhood. Approximately one-half of all infants are infected with RSV during the first year of life, and nearly all children have been infected at least once by the time they reach their second bir
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
2. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
3. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
4. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
5. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
6. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
7. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
8. Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
9. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:3/2/2015)... , March 2, 2015 Cardinal Health ... business, a leading global manufacturer of cardiology and endovascular ... billion, net of the present value of tax benefits. ... combination of $1.0 billion in new senior unsecured notes ... expected to close in the United States ...
(Date:3/2/2015)... DUBLIN , March 2, 2015   ... device businesses for a total consideration of up to $1.65 ... Endo also evaluating strategic alternatives for AMS, Women,s Health ... into a global specialty pharmaceuticals business ... today announced it has entered into a definitive agreement with ...
(Date:3/2/2015)... WOODLANDS, Texas , March 2, 2015   ... a biopharmaceutical company focused on developing breakthrough treatments for ... end 2014 financial results on Wednesday, March 4, 2015 ... a conference call and webcast to discuss clinical development ... year end of 2014 at 10:00 a.m. Eastern Time ...
Breaking Medicine Technology:Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 2Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 3Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 4Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 5Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 6Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 7Endo Announces Divestiture of American Medical Systems' Men's and Prostate Health Businesses to Boston Scientific 2Endo Announces Divestiture of American Medical Systems' Men's and Prostate Health Businesses to Boston Scientific 3Lexicon To Report Fourth Quarter And Year End 2014 Financial Results On March 4, 2015 2
... Academy of Neurology Annual Meeting,Show Approximately 50 ... 01, 2007 /PRNewswire/ -- Data from two ... of Neurology (AAN),meeting suggest that an investigational ... is effective as add-on,treatment in patients with ...
... Sleep Interference, INDIANAPOLIS, May 03, 2007 /PRNewswire-FirstCall/ -- ... that in patients with pain,caused by diabetic nerve ... Cymbalta (duloxetine HCl), improvements in,both average daily pain ... sleep interference than in those patients,taking sugar pill. ...
Cached Medicine Technology:New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 2New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 3New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 4New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 5Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 2Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 3Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 4Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 5Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 6
(Date:3/2/2015)... Final Cut Pro X plugin specialists have ... Film Studios. , “The TranStatic Volume 2 plugin gives users ... CEO of Pixel Film Studios. “TranStatic Volume 2 is a ... editors toolbox.” , With TranStatic Volume 2 users can transition ... scrambling effects from Pixel Film Studios. Users have total control ...
(Date:3/1/2015)... As residents and business owners in Southlake, ... Carita Weaver, believe in supporting local organizations and ... Chamber of Commerce, Carroll Independent School District and ... website for Southlake mayoral candidate Laura Hill: ... Hill’s campaign, the website combines images, videos and ...
(Date:3/1/2015)... March 01, 2015 Adults who are ... rates for term or universal policies can now use ... the best life insurance companies for single adults can ... at http://quotespros.com/life-insurance.html . , The rate plans that ... are tied to a number of life protection policies. ...
(Date:3/1/2015)... York, NY (PRWEB) March 01, 2015 ... has grown substantially over the past few weeks in ... LLP are actively filing claims, the Firm announces. ... reflects 7,713 cases in the Bergen County proceeding established ... Inc., compared with a few weeks earlier, when 90 ...
(Date:3/1/2015)... 2015 Theme and plugin developers from ... pack for Final Cut Pro X entitled Transccordion. ... to any FCPX editors project.” Said Christiana Austin, CEO ... tools needed to easily drag and drop their accordion ... many different controls over the parameters of this transition ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2Health News:Website Launched for Southlake, Texas Mayoral Candidate Laura Hill 2Health News:Best Life Insurance Companies for Single Adults Now Searchable at Insurance Website 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 4Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2
... N.J., April 1, 2008 Defined Health has,announced ... for its 8th,annual Therapeutic Insight conference. Therapeutic Insight ... 30, 2008, at The Westin New York at ... registration information,along with content and attendee statistics from ...
... Association of,Health Plans (OAHP), the statewide trade association of ... Ohioans, announced the,election of new officers this week., ... chair of OAHP.,Crampton is the Chair of the Board ... serving the Ohio CFC Medicaid program in,the Northwest and ...
... 1, 2008 Core People Resources,today announced a ... Wexford, PA. CCSC provides options in healthcare coverage ... chamber members through,its ChamberChoice portfolio., The partnership ... level of employer services, including comprehensive human resource,outsourcing ...
... 2008 Leading consumer,employer and labor organizations ... physician groups and health insurers on principles,to ... and report the,information to consumers., The ... Tiering Programs" announced today creates a national ...
... Turns Assets from Retirement Plans Into Guaranteed Income ... ... NEW YORK, April 1, 2008 AXA Equitable Life,Insurance ... new variable annuity -- Crossings(SM): My Lifetime,IRA(SM), designed specifically as ...
... Acomplia might help fight coronary disease , , TUESDAY, April 1 ... not help slow atherosclerosis, a buildup of arterial plaque that,s ... trial did not find any evidence that the drug actually ... one measure of plaque build-up in arteries. , Acomplia ...
Cached Medicine News:Health News:Shannon Brownlee, Author of 'Overtreated,' to Keynote at Defined Health's 8th Annual Therapeutic Insight Conference 2Health News:Ohio Association of Health Plans Announces New Officers 2Health News:Core People Partners to Expand Services 2Health News:Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting 2Health News:Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting 3Health News:Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting 4Health News:Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting 5Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 2Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 3Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 4Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 5Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 6Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 7Health News:Obesity Drug Shows Mixed Success Against Atherosclerosis 2Health News:Obesity Drug Shows Mixed Success Against Atherosclerosis 3
... The Modular Shoulder System* ... surgeons with a comprehensive range ... of individual patient needs. With ... Smith + Nephew offers a ...
... The Bio-Modular, for ... shoulder replacement. Modularity in ... range of sizing and ... with one of the ...
... The Bigliani/Flatow shoulder allows for the ... cases of shoulder replacement surgery. Backed ... and decades of experience, the Bigliani/Flatow ... the natural shoulder's mobility, balance, and ...
Comprehensive, unified system for total or hemi shoulder arthroplasty....
Medicine Products: